Table 1.
Demographic and clinical characteristics (frequencies or means±SDs) of participants in each group and site.
| Site | Group | N, #Males, # Females | Age (years) | CDR | MoCA | Baseline ADAS-Cog | CSDD | HIS (modified version) |
|---|---|---|---|---|---|---|---|---|
| Winnipeg | R2 | 25 (14 M, 11 F) | 72.9 ± 7.6 | 1.08 ± 0.37 | 13.8 ± 5.2 | 25.8 ± 7.1 | 3.5 ± 2.9 | 2.6 ± 1.8 |
| R4 | 24 (15 M, 9 F) | 72.4 ± 7.4 | 1.12 ± 0.34 | 17.0 ± 5.4 | 21.7 ± 8.0 | 3.0 ± 2.7 | 2 ± 2.1 | |
| S4 | 23 (15 M, 8 F) | 73.5 ± 9.7 | 1.09 ± 0.29 | 17.3 ± 4.5 | 21.2 ± 8.0 | 4.2 ± 3.8 | 2.6 ± 1.3 | |
| Montreal | R2 | 15 (7 M, 8 F) | 72.8 ± 11.5 | 1.13 ± 0.35 | 16.1 ± 4.5 | 24.9 ± 10.3 | 5.2 ± 4.0 | 1.1 ± 0.9 |
| R4 | 16 (7 M, 9 F) | 72.4 ± 6.7 | 1.19 ± 0.40 | 13.4 ± 5.4 | 29.9 ± 11.2 | 5.6 ± 2.7 | 1.2 ± 1.5 | |
| S4 | 16 (6 M, 10 F) | 72.9 ± 7.4 | 1.19 ± 0.40 | 16.1 ± 4.4 | 25.1 ± 8.5 | 5.4 ± 3.4 | 1.6 ± 1.3 | |
| Melbourne | R2 | 12 (11 M, 1 F) | 76.9 ± 3.9 | 1.17 ± 0.39 | 15.8 ± 4.1 | 21.4 ± 5.0 | 3.7 ± 2.2 | 2.8 ± 1.6 |
| R4 | 13 (5 M, 8 F) | 76.1 ± 5.9 | 1.23 ± 0.44 | 15.8 ± 5.2 | 24.3 ± 13.0 | 4.4 ± 4.7 | 1.2 ± 1.5 | |
| S4 | 12 (5 M, 7 F) | 80.7 ± 8.2 | 1.17 ± 0.39 | 12.6 ± 3.9 | 24.1 ± 8.5 | 3.4 ± 2.9 | 1.6 ± 1.3 | |
| All sites | R2 | 52 (32 M, 20 F) | 73.8 ± 8.3 | 1.12 ± 0.37 | 14.9 ± 4.8 | 24.4 ± 7.9 | 4.0 ± 3.2 | 2.2 ± 1.7 |
| R4 | 53 (27 M, 26 F) | 73.3 ± 6.9 | 1.17 ± 0.38 | 15.6 ± 5.5 | 24.9 ± 10.8 | 4.1 ± 3.4 | 1.9 ± 1.9 | |
| S4 | 51 (26 M, 25 F) | 75.0 ± 9.1 | 1.14 ± 0.35 | 15.8 ± 4.6 | 23.1 ± 8.3 | 4.4 ± 3.5 | 2.3 ± 1.7 | |
| Total | All | 156 (85 M, 71 F) | 74.0 ± 8.1 | 1.14 ± 0.36 | 15.4 ± 5.0 | 24.2 ± 9.1 | 4.2 ± 3.3 | 2.2 ± 1.8 |